Actively Recruiting
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
Led by Gruppo Oncologico Italiano di Ricerca Clinica · Updated on 2024-08-12
80
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
Sponsors
G
Gruppo Oncologico Italiano di Ricerca Clinica
Lead Sponsor
Y
Yghea
Collaborating Sponsor
AI-Summary
What this Trial Is About
CABOGEN is a Observational, retrospective, multicenter study that will enroll patients with metastatic clear cell renal carcinoma (mccRCC) treated with cabozantinib after one or more previous lines of treatment that included TKIs, immune checkpoint inhibitors or mTOR inhibitors.
CONDITIONS
Official Title
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63 18 years
- Histological diagnosis of predominantly clear cell carcinoma
- Availability of tumor tissue from primary tumor and/or metastatic site for genomic profiling analysis not older than 5 years
- Disease evaluable according to RECIST criteria version 1.1
- Treatment with cabozantinib after one or more previous therapies for metastatic renal cell carcinoma
- Patient progressed from start of cabozantinib therapy within 3 months or after 9 months
- Any prognosis group according to IMDC risk score
- Signed informed consent obtained for living patients; deceased or untraceable patients analyzed per Italian Data Protector Supervisor authorization
You will not qualify if you...
- Non-availability of tumor tissue from primary tumor or metastatic site for biomarker analysis
- Patient progressed between 3 and 9 months from beginning of cabozantinib treatment
- Non-availability of clinical information to evaluate IMDC risk group at baseline
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
AUSL-IRCCS of Reggio Emilia
Reggio Emilia, Italy, 42123
Actively Recruiting
Research Team
C
Carmine Pinto, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here